Ani Pharmaceuticals, Inc. · NASDAQ:ANIP
Ani Pharmaceuticals, Inc. shareholders
As of Jun 30, 2026, 295 institutions reported holding Ani Pharmaceuticals, Inc. Largest: BlackRock, Vanguard and Soleus Capital Management, L.P. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Ani Pharmaceuticals, Inc. | Change | Filed |
|---|---|---|---|---|
| BlackRock | 2.96M | +211K | Aug 7, 2026 | |
| Vanguard | 1.4M | +55,076 | Aug 13, 2026 | |
| Soleus Capital Management, L.P. | 868K | +47,517 | Aug 11, 2026 | |
| State Street | 832K | +60,060 | Aug 7, 2026 | |
| Tang Capital Management LLC | 708K | no change | Aug 14, 2026 | |
| Dimensional | 623K | +92,273 | Aug 11, 2026 | |
| American Century | 574K | +383K | Aug 12, 2026 | |
| Arrowstreet Capital, Limited Partnership | 562K | −2,344 | Aug 13, 2026 | |
| Global Alpha Capital Management Ltd. | 558K | +197K | Aug 13, 2026 | |
| Geode Capital | 536K | +47,206 | Aug 12, 2026 |